JPS59196303A - Biguanide polymer - Google Patents

Biguanide polymer

Info

Publication number
JPS59196303A
JPS59196303A JP7002083A JP7002083A JPS59196303A JP S59196303 A JPS59196303 A JP S59196303A JP 7002083 A JP7002083 A JP 7002083A JP 7002083 A JP7002083 A JP 7002083A JP S59196303 A JPS59196303 A JP S59196303A
Authority
JP
Japan
Prior art keywords
biguanide
formula
compound
group
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7002083A
Other languages
Japanese (ja)
Other versions
JPH0319849B2 (en
Inventor
Shigeo Tatsuki
田附 重夫
Tomiki Ikeda
富樹 池田
Takuo Uejima
上島 卓雄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PAAMAKEMU ASIA KK
Permachem Asia Ltd
Original Assignee
PAAMAKEMU ASIA KK
Permachem Asia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PAAMAKEMU ASIA KK, Permachem Asia Ltd filed Critical PAAMAKEMU ASIA KK
Priority to JP7002083A priority Critical patent/JPS59196303A/en
Publication of JPS59196303A publication Critical patent/JPS59196303A/en
Publication of JPH0319849B2 publication Critical patent/JPH0319849B2/ja
Granted legal-status Critical Current

Links

Abstract

PURPOSE:A biguanide polymer having a biguanide residue in a side chain and a high antimicrobial activity and useful as an external bactericide or a bactericide for industrial water, etc., prepared by polymerizing a specified vinyl compound having a biguanide residue. CONSTITUTION:The present invention biguanide polymer of an excellent antibacterial activity is represented by formula I or II (wherein R1 and R2 are each H or a halogen, A is a group -CHR3-CHR4-, n>=2, p and q each >=1, R3 is carboxy, alkoxy-carbonyl, phenyl, 2-pyridyl, carbamoyl or the like and R4 is H or methyl). The biguanide polymer of formula I can be prepared by polymerizing a biguanide residue-containing vinyl compound of formula III. The biguanide polymer of formula II can be obtained by polymerizing a vinyl compound of formula III with a compound of formula IV (e.g., acrylic acid).

Description

【発明の詳細な説明】 本発明はビグアニド基を有する抗菌性高分子化合物に関
する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an antibacterial polymeric compound having a biguanide group.

抗菌剤、制菌剤、殺菌剤、防黴剤などの抗微生物薬剤は
年々用途が拡大され、医薬としてのみならず食品工業、
機械工業、製紙工業、繊維工業、環境衛生管理など各種
の分野で、種々の性能が要求されている。一般的な要求
性能として、抗微生物活性が高く、かつその作用スペク
トルが広(・ことを第一義としながらも、人畜への無毒
性、無臭性、保存安定性、取扱いの容易さなど副次的な
性能が実用的価値を決定する要因である、現在まで多種
多様の薬剤が開発されているが、これらの諸要件を同時
に満たすことは至難である(昭)■56年発行堀ロ博著
「殺菌・防黴の化学」参照)。本発明者らは、工業的に
も環境衛生上も優れた性質を有する化合物を求めて鋭意
研究を行った結果、ビグアニド残基を有する新規ビニル
化合物を合成し、次いでこのビニル化合物を重合させて
、側鎖にビグアニド残基を有する高分子化合物を得た。
Antimicrobial agents such as antibacterial agents, antibacterial agents, bactericidal agents, and antifungal agents are being used more and more every year, and are used not only as pharmaceuticals but also in the food industry,
Various performances are required in various fields such as the mechanical industry, paper industry, textile industry, and environmental hygiene management. Generally required performance is high antimicrobial activity and a wide spectrum of action. Although a wide variety of drugs have been developed to date, the performance of which determines their practical value, it is extremely difficult to satisfy all of these requirements at the same time. (See "Chemistry of sterilization and anti-mold"). As a result of intensive research in search of a compound with excellent properties both industrially and in terms of environmental hygiene, the present inventors synthesized a new vinyl compound having a biguanide residue, and then polymerized this vinyl compound. , a polymer compound having biguanide residues in the side chain was obtained.

そしてこの高分子化合物は前記の諸条件を満たす優れた
抗菌剤であるばかりでなく単量体よりも抗菌力が優れて
いるという事実大見出した。
We have discovered that this polymer compound is not only an excellent antibacterial agent that satisfies the above conditions, but also has superior antibacterial activity than the monomer.

本発明は、一般式 (式中R1及びR2は水素原子又はハロゲン原子、Aは
基−CHR3−CHR4−1nは2以上の整数、p及び
qは1以上の整数を示し、基R3はカルバモイル基、カ
ルボキシ基、アルコキシカルボニル基、フェニル基、2
−ピリジル基又は2−オキソピロジニ、ル基、R4は水
素原子又はメチル基を意味する)で表わされるビグアニ
ド系重合体である。
The present invention is based on the general formula (wherein R1 and R2 are hydrogen atoms or halogen atoms, A is a group -CHR3-CHR4-1n is an integer of 2 or more, p and q are integers of 1 or more, and the group R3 is a carbamoyl group. , carboxy group, alkoxycarbonyl group, phenyl group, 2
-pyridyl group or 2-oxopyrrodinyl group, R4 means a hydrogen atom or a methyl group).

式■及びHの化合物の置換基R2及びR3のためのハロ
ゲン原子としては、特に塩素原子が好ましい。nは通常
は10〜500であり、p+qは10〜500、q:p
比は1:0.5〜100である。
As the halogen atom for the substituents R2 and R3 in the compounds of formulas (1) and (H), a chlorine atom is particularly preferred. n is usually 10-500, p+q is 10-500, q:p
The ratio is 1:0.5-100.

本発明の高分子化合物は、低重合度の酸塩の場合は水溶
性であり、同時にアルコール等の有機溶媒にも可溶であ
る。重合度が高くになるにつれて溶解性は減少する。ま
た架橋されて6次元網目構造を有する高分子は不溶性で
あるが抗菌性を有している。
The polymer compound of the present invention is water-soluble in the case of an acid salt having a low degree of polymerization, and is also soluble in organic solvents such as alcohol. Solubility decreases as the degree of polymerization increases. Further, a crosslinked polymer having a six-dimensional network structure is insoluble but has antibacterial properties.

ビグアニド基を含む化合物が抗菌性を有することは既に
知られているが、これを高分子側鎖に結合して利用する
発想及びそれに由来する技術的利点は下記のとおりであ
る。■)ビグアニド残基はカチオン性であるため、負電
荷を帯びた細胞膜表面と相互作用する。ここに高分子化
した効果は多くのカチオンが相乗的に相互作用に参加す
ることにある。その結果、細胞膜近傍のビグアニド残基
濃度を著しく高めることが可能となる。n)薬理学的検
討よりビグアニド残基は細胞膜攻撃型の抗菌剤であるた
め菌体内に取り込まれる必要は−ない。したがって高分
子化による細胞膜透過性の低下は不利な要因とはならず
、前記■)の効果により正の高分子効果が発揮される。
Although it is already known that compounds containing biguanide groups have antibacterial properties, the idea of utilizing them by bonding them to polymer side chains and the technical advantages derived therefrom are as follows. ■) Since biguanide residues are cationic, they interact with the negatively charged cell membrane surface. The effect of polymerization is that many cations synergistically participate in the interaction. As a result, it becomes possible to significantly increase the concentration of biguanide residues near the cell membrane. n) Pharmacological studies have shown that biguanide residues are antibacterial agents that attack cell membranes, so there is no need for them to be incorporated into bacterial cells. Therefore, the decrease in cell membrane permeability due to polymerization does not become a disadvantageous factor, and a positive polymer effect is exerted due to the effect (2) above.

I)高分子であることは人畜に対する毒性低下、無臭化
、保存安定性、取扱いの容易さなど全ての副次的性能の
面で有利である。IV) n)で述べた作用機作より明
らかなように、この化合物は代謝阻害型抗菌剤ではない
ため、菌体内に耐性菌発生の原因となる抗菌剤分解酵素
を造り出す可能性は少ない。
I) Being a polymer is advantageous in terms of all secondary performances such as reduced toxicity to humans and animals, odorlessness, storage stability, and ease of handling. IV) As is clear from the mechanism of action described in n), this compound is not a metabolism-inhibiting antibacterial agent, so it is unlikely to produce antibacterial degrading enzymes that cause the development of resistant bacteria within bacterial cells.

式■の化合物は、一般式 2 ■ (式中R8及びR2は前記の意味を有する)で表わされ
る化合物を重合することにより得られる。
The compound of formula (2) can be obtained by polymerizing a compound represented by general formula (2) (in which R8 and R2 have the above-mentioned meanings).

式1の化合物は新規物質であって、例えば下記の合成経
路′把より製造することができる(同日付特許出願明細
書参照)。
The compound of formula 1 is a new substance and can be produced, for example, by the following synthetic route (see patent application specification dated the same date).

■ 弐■の化合物は酸付加塩例えば塩酸塩、硝酸塩として用
いることが好ましい。これらの酸付加塩は常法により製
造することができる。
(2) The compound (2) is preferably used as an acid addition salt, such as a hydrochloride or a nitrate. These acid addition salts can be produced by conventional methods.

式■の化合物は、式■の化合物と一般式CHR3=CH
R4■ (式中R5及びR4は前記の意味を有する)で表わされ
る化合物を重合することにより得られる。
The compound of formula ■ is a compound of formula ■ and the general formula CHR3=CH
It can be obtained by polymerizing a compound represented by R4 (in the formula, R5 and R4 have the above-mentioned meanings).

弐■の化合物としては例えばアクリル酸、メタクリル酸
又4よそのエステル、アクリルアミド、ビニルピロリド
ン、ビニルピリジン、スチレン、ヒドロキシエチルメタ
クリレート、メチレンビスアクリルアミド等が用いられ
る。
As the compound (2), for example, acrylic acid, methacrylic acid or other esters thereof, acrylamide, vinylpyrrolidone, vinylpyridine, styrene, hydroxyethyl methacrylate, methylenebisacrylamide, etc. are used.

式ハ1の化合物は、式■の化合物1モルに対し、0.5
〜100モルの割合で用いることが好ましい。
The compound of formula C1 is 0.5% per mole of the compound of formula II.
It is preferable to use it in a proportion of 100 moles.

重合反応を行うに際しては、前記の化合物を溶媒に溶解
した0ち、これに重合開始剤を添加する。
When carrying out a polymerization reaction, the above compound is dissolved in a solvent, and then a polymerization initiator is added thereto.

溶媒としては例えば水、メタノール、エタノール、ジメ
チルホルムアミドなど並びにこれらの混合物が用いられ
る。重合開始剤としては例えば2,2′−アゾビス=(
2−アミジノプロパン)、2.2’−アゾビスイソブチ
ロニトリル、過酸化ベンゾイル、t−ブチルハイドロパ
ーオキサイド等が用いられる。
Examples of solvents used include water, methanol, ethanol, dimethylformamide, and mixtures thereof. As a polymerization initiator, for example, 2,2'-azobis=(
2-amidinopropane), 2,2'-azobisisobutyronitrile, benzoyl peroxide, t-butyl hydroperoxide, and the like.

反応温度は60〜80℃が好ましい。反応は通常60分
で終了する。反応温度を高くすると反応時間は短縮でき
るが、重合度が低下する傾向がある。
The reaction temperature is preferably 60 to 80°C. The reaction usually completes in 60 minutes. Although the reaction time can be shortened by increasing the reaction temperature, the degree of polymerization tends to decrease.

反応終了後、反応混合物を大量のアセトン中に注入し、
析出する沈殿を戸取すると、目的の高分子化合物が得ら
れる。
After the reaction is complete, the reaction mixture is poured into a large amount of acetone,
The desired polymer compound can be obtained by collecting the precipitate.

式■及び■の化合物は抗微生物活性が高(、抗菌剤とし
て有用である。これらの化合物は、例えば外用殺菌剤、
繊維、布等の・衛生加工用殺菌剤、プール、工業用水等
の殺菌剤として用いられる。
The compounds of formulas ■ and ■ have high antimicrobial activity (and are useful as antibacterial agents. These compounds can be used, for example, as external disinfectants,
Used as a disinfectant for textiles, cloth, etc., sanitary processing, swimming pools, industrial water, etc.

弐■の化合物の合成例 p−アミノフェネチルアルコール51 jj (0゜3
7モル)をジオキサン550 mlに溶解する。
Synthesis example of compound 2■ p-aminophenethyl alcohol 51 jj (0゜3
7 mol) in 550 ml of dioxane.

この溶液に室温で塩化水素ガスを60分間導通したのち
、析出沈殿を戸数すると、p−アミノフェネチルアルコ
ール塩酸塩50.9が得られる(収率77佑、融点17
0〜172°C)。このp−アミノフェネチルアルコー
ル塩酸塩17.4.9(o、1モール)及びナトリウム
ジシアンイミド9.0.9(0,1モル)を、水20D
mg中で90’Cに加熱して2時間反応させると、p−
ヒドロキシエチルフェニルジシア、ンジアミド16.a
gが得られる(収率68%、融点172〜175°C)
After passing hydrogen chloride gas through this solution at room temperature for 60 minutes, the precipitate was separated to obtain 50.9 g of p-aminophenethyl alcohol hydrochloride (yield: 77 yu, melting point: 17
0-172°C). This p-aminophenethyl alcohol hydrochloride 17.4.9 (o, 1 mol) and sodium dicyanimide 9.0.9 (0.1 mol) were added to 20 d of water.
When heated to 90'C and reacted for 2 hours in p-
Hydroxyethyl phenyl disia, diamide 16. a
g (yield 68%, melting point 172-175°C)
.

p−ヒドロキシエチルフェニルジシアンジアミド15.
 Oi (0,074モル)をテトラヒドロフラン82
uj!−水9 mlの混合溶媒に溶解し、水浴中でアク
リル酸クロリド48meを滴下する。
p-Hydroxyethylphenyldicyandiamide 15.
Oi (0,074 mol) in tetrahydrofuran 82
uj! - Dissolve in a mixed solvent of 9 ml of water, and add acrylic acid chloride 48me dropwise in a water bath.

滴下終了後、室温で一夜放置したのち、析出した沈殿を
戸数すると、p−アクリロイルエチルフェニルジシアン
ジアミド1” 7.8 Fが得られる(収率94%、融
点157〜159°C)。
After completion of the dropwise addition, the mixture was allowed to stand overnight at room temperature, and the precipitate was collected to give p-acryloylethylphenyldicyandiamide 1''7.8 F (yield 94%, melting point 157-159°C).

p−アクリロイルエチルフェニルジシアンジアミドs、
7.y(o、o64モル)及びp−クロルアニリン塩酸
塩5.59 (0,034モル)を、イングロビルアル
コール60 ml中で10分間還流加熱する。冷却後、
析出した沈殿を戸数すると、1−7り’)ロイルエチル
フェニル−5−p−1’ロルフエニルビグアニド塩酸塩
9.7Iが得られる(収率69%、融点:204〜20
6℃、分解)。
p-acryloylethylphenyldicyandiamide s,
7. y (o, o64 mol) and p-chloroaniline hydrochloride 5.59 (0,034 mol) are heated under reflux for 10 minutes in 60 ml of Inglovir alcohol. After cooling,
When the precipitate was collected, 9.7I of loylethylphenyl-5-p-1'lolylethylphenyl biguanide hydrochloride was obtained (yield 69%, melting point: 204-20
6°C, decomposition).

同様にして下記の化合物が得られる。Similarly, the following compounds are obtained.

1−アクリロイルエチルフェニル−5−フェニルビグア
ニド塩酸塩、融点:182〜185・C1(分解)。
1-Acryloylethylphenyl-5-phenylbiguanide hydrochloride, melting point: 182-185.C1 (decomposed).

1−アクリロイルエチルフェニル−5−(3,4−ジク
ロルフェニル)ビグアニド塩酸塩、融点:186〜18
9℃、(分解)。
1-Acryloylethylphenyl-5-(3,4-dichlorophenyl)biguanide hydrochloride, melting point: 186-18
9°C, (decomposition).

実施例1 1−4’クリロイルエチルフェニル−5−p−クロルフ
ェニルビグアニド塩酸塩2.08.!l”メチルホルム
アミド10m1に溶解し、2,2′−アゾビス−2−ア
ミジノプロノ(ン塩酸塩12.4 R9を添加して脱気
封管する。これを60°Cで6.5時間放置して重合さ
せたのち、大過剰のアセトン中に注ぎ込み、析出する沈
殿を戸数すると、ホ1J(1−7り’)ロイルエチルフ
ェニル−p−10ルフェニルビグアニド塩酸塩) 1.
 6 9gが得られる。
Example 1 1-4'Cryloylethylphenyl-5-p-chlorophenyl biguanide hydrochloride 2.08. ! Dissolve the solution in 10 ml of methylformamide, add 12.4 R9 of 2,2'-azobis-2-amidinopronone hydrochloride, and degas and seal the tube. Leave this at 60°C for 6.5 hours. After polymerization, it was poured into a large excess of acetone, and the precipitate that precipitated was counted.
69g is obtained.

実施例2 1−アクリロイルエチルフェニル−5−フェニルビグア
ニド塩酸塩1.2・g( 6.1ミリモル)及び重合開
始剤である2,2′−アゾビス(2−アミジノプロパン
)2塩酸塩14m57をジメチルホルムアミド12ml
中に溶解する。以下実施例1と同様に処理すると、ポリ
(1−アクリロイルエチルフェニル−5−フェニルビグ
アニド塩酸塩)0.84gが得られる(収率70%)。
Example 2 1.2 g (6.1 mmol) of 1-acryloylethylphenyl-5-phenylbiguanide hydrochloride and 14 m57 of 2,2'-azobis(2-amidinopropane) dihydrochloride as a polymerization initiator were dissolved in dimethyl 12ml formamide
dissolve in Thereafter, the same treatment as in Example 1 is performed to obtain 0.84 g of poly(1-acryloylethylphenyl-5-phenylbiguanide hydrochloride) (yield 70%).

4、8(s,ビグアニド基のプロトン)実施例6 1−アクリロイルエチルフェニル−5 − (3.4−
ジクロルフェニル)ビグアニド塩酸塩1.2g(2.6
ミリモル)を実施例2と同様にして重合すると、ポリ〔
1−アクリロイルフェニル−5− ( 6.4−ジクロ
ルフェニル)ビグアニド塩酸塩〕0、6’6gが得られ
る(収率57%)。
4,8 (s, proton of biguanide group) Example 6 1-acryloylethylphenyl-5- (3.4-
dichlorophenyl) biguanide hydrochloride 1.2 g (2.6
mmol) was polymerized in the same manner as in Example 2, poly[
0.6'6 g of 1-acryloylphenyl-5-(6.4-dichlorophenyl)biguanide hydrochloride is obtained (yield 57%).

wR(aD,oD) 4、8(s,ビグアニド基のプロトン)実施例4 1−アクリロイルエチルフェニル−5−I−p−クロル
フェニルビグアニド塩酸塩4.5g、アクリルアミド0
.51g及び2,2′−アゾビス−2−アミジノプロパ
ン塩酸塩60m9をジメチルホルムアミド−水(1:1
)の混合溶媒50mlに溶解し、実施例2と同様に脱気
封管後、60℃で重合させる。20分後に反応混合物を
大量のアセトン中に注ぎ込み、析出する沈殿を戸数する
と、目的の共重合体3. 8 6 gが得られる。吸収
スペクトル法により、この共重合体の組成を決位 定したところ、ビグアニドを含む単;Wは42.6Δ モル%、アクリルアミド′単位は57.7%であった。
wR (aD, oD) 4, 8 (s, proton of biguanide group) Example 4 1-acryloylethylphenyl-5-I-p-chlorophenyl biguanide hydrochloride 4.5 g, acrylamide 0
.. 51 g and 60 m9 of 2,2'-azobis-2-amidinopropane hydrochloride were dissolved in dimethylformamide-water (1:1
) in 50 ml of a mixed solvent, and after degassing and sealing the tube in the same manner as in Example 2, polymerization was carried out at 60°C. After 20 minutes, the reaction mixture was poured into a large amount of acetone and the precipitate was collected, resulting in the desired copolymer 3. 8 6 g is obtained. The composition of this copolymer was determined by absorption spectroscopy, and the content of biguanide-containing units was 42.6Δ mol%, and the content of acrylamide' units was 57.7%.

実施例5 1−アクリロイルエチルフェニル−5−p−クロルフェ
ニルビグアニド塩酸塩2.15g(5。
Example 5 1-Acryloylethylphenyl-5-p-chlorophenyl biguanide hydrochloride 2.15 g (5.

1ミリモル)及びN−ビニルピロリドン0.85j;l
 ( 7. 7ミリモル)をジメチルホルムアミド25
ml中で脱気下にラジカル重合させる。重合開始剤とし
て2,2′−アゾビス−(2−アミジノプロパン)2塩
酸塩25m9を用い、60°Cで20分間放置し、冷却
後、反応混合物を大量のアセトン中に注ぎ込み、析出す
る沈殿を戸数すると、目的の共重合体1.6gが得られ
る。
1 mmol) and N-vinylpyrrolidone 0.85j; l
(7.7 mmol) in dimethylformamide 25
ml under degassing. Using 25 m9 of 2,2'-azobis-(2-amidinopropane) dihydrochloride as a polymerization initiator, it was left at 60°C for 20 minutes, and after cooling, the reaction mixture was poured into a large amount of acetone to remove the precipitate. When mixed, 1.6 g of the desired copolymer was obtained.

NMR(CD30D, s ) 1、0〜2J(br、ビニルピロリドン重合体)2、6
〜4.0(br、ビニルピロリドン重合体)4、67(
s、ビグアニド基のプロトン)7、30(s,芳香核の
プロトン) 試験例1 式■及び■の化合物のミクロコツカス・パイオゲネス・
バール・アウレウスに対する抗菌活性を溶液希釈法によ
り測定した。
NMR (CD30D, s) 1,0-2J (br, vinylpyrrolidone polymer) 2,6
~4.0(br, vinylpyrrolidone polymer) 4,67(
s, proton of biguanide group) 7, 30 (s, proton of aromatic nucleus) Test Example 1 Micrococcus pyogenes of compounds of formulas ■ and ■
Antibacterial activity against Burl aureus was measured by solution dilution method.

溶液希釈法二所定濃度の薬剤希釈液中に所定量の菌を摂
種し、一定接触時間毎にその液の一部を取り出し菌数を
測定した。接触時間に対し菌数の減少が著しいほど抗菌
活性が強いことを示している。表中の数字は菌数(個/
 rue )を示す。
Solution dilution method 2 A predetermined amount of bacteria was inoculated into a drug dilution solution with a predetermined concentration, and a portion of the solution was taken out at regular contact times to measure the number of bacteria. The more remarkable the decrease in the number of bacteria with respect to the contact time, the stronger the antibacterial activity. The numbers in the table are the number of bacteria (numbers/
rue).

弐■の化合物の結果を第1表にまた式■の化合物の結果
を第2表に示す。式■の化合物としては、実施例4と同
じ単量体を混合比を変えて反応させることにより得られ
た共重合体を用いた。
The results for the compound of formula (2) are shown in Table 1, and the results for the compound of formula (2) are shown in Table 2. As the compound of formula (2), a copolymer obtained by reacting the same monomers as in Example 4 with different mixing ratios was used.

また比較例としてはR,及びR2が塩素原子である式■
の化合物を用いた。
Also, as a comparative example, the formula ■ where R and R2 are chlorine atoms
The compound was used.

注:括弧内はq:p比を示す。Note: The q:p ratio is shown in parentheses.

試験例ま た。ミクロコツカス・パイオケネス・バール・アウレウ
ス(M、P )及びバチルス・ズブチリス(B、S )
菌液(約106個/ml ) 0.5 mlを試験片及
びその周囲の培地に散布した。これを67°Cで72時
間培養し、菌の発育の程度を観察した。
Another test example. Micrococcus pyocenes var aureus (M, P) and Bacillus subtilis (B, S)
0.5 ml of the bacterial solution (approximately 106 cells/ml) was sprinkled on the test piece and the surrounding medium. This was cultured at 67°C for 72 hours, and the degree of bacterial growth was observed.

その結果を第6表に示す。なお弐■の化合物としては実
施例2の化合物、式Hの化合物としては試験例1と同じ
化合物を用い、比較例としてはアクリルアミド重合体の
フィルム状試験片を用℃・た。
The results are shown in Table 6. The compound of Example 2 was used as the compound (2), the same compound as in Test Example 1 was used as the compound of formula H, and a film-like test piece of an acrylamide polymer was used as a comparative example.

Claims (1)

【特許請求の範囲】 一般式 (式中R8及び−1(2は水素原子又はハロゲン原子、
Aは基−CHR3CHR4−1nは2以上の整数、p及
びqは1以上の整数を示し、基R3はカルボキシ基、ア
ルコキシカルボニル基、フェニル基、2−ピリジル基、
カルバモイル基又は2−オキソピロジニル基、R4は水
素原子又はメチル基を意味する)で表わされるビグアニ
ド系重合体。
[Claims] General formula (wherein R8 and -1 (2 is a hydrogen atom or a halogen atom,
A is a group -CHR3CHR4-1n is an integer of 2 or more, p and q are integers of 1 or more, and the group R3 is a carboxy group, an alkoxycarbonyl group, a phenyl group, a 2-pyridyl group,
A biguanide polymer represented by a carbamoyl group or a 2-oxopyrrodinyl group (R4 means a hydrogen atom or a methyl group).
JP7002083A 1983-04-22 1983-04-22 Biguanide polymer Granted JPS59196303A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7002083A JPS59196303A (en) 1983-04-22 1983-04-22 Biguanide polymer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7002083A JPS59196303A (en) 1983-04-22 1983-04-22 Biguanide polymer

Publications (2)

Publication Number Publication Date
JPS59196303A true JPS59196303A (en) 1984-11-07
JPH0319849B2 JPH0319849B2 (en) 1991-03-18

Family

ID=13419502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7002083A Granted JPS59196303A (en) 1983-04-22 1983-04-22 Biguanide polymer

Country Status (1)

Country Link
JP (1) JPS59196303A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002542847A (en) * 1999-05-01 2002-12-17 バイオインターラクションズ リミテッド Infection resistant polymers and their preparation and use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002542847A (en) * 1999-05-01 2002-12-17 バイオインターラクションズ リミテッド Infection resistant polymers and their preparation and use
JP4713743B2 (en) * 1999-05-01 2011-06-29 バイオインターラクションズ リミテッド Infection resistant polymers and their preparation and use

Also Published As

Publication number Publication date
JPH0319849B2 (en) 1991-03-18

Similar Documents

Publication Publication Date Title
US5902818A (en) Surface active N-halamine compounds
Ikeda et al. New polymeric biocides: synthesis and antibacterial activities of polycations with pendant biguanide groups
WO1996008949A2 (en) Novel monomeric and polymeric cyclic amine and n-halamine compounds
US6469177B1 (en) Surface active N-Halamine compounds
WO1994001474A1 (en) Polymerizable monomer, polymer thereof, and process for producing the same
JP3332920B2 (en) Antibacterial agent
EP0676437B1 (en) Use of polycationic polymer as bactericidal/algicidal agent
JPS59196303A (en) Biguanide polymer
JPS61138607A (en) Polymerization of water-soluble cationic polymer
JPS62230806A (en) Guanidine group-containing polymer and production thereof
US4359555A (en) Salts formed from formamidines with polymers containing sulfonic acid groups
JP3171691B2 (en) Copolymer and method for producing the same
JP3178557B2 (en) Homopolymer and method for producing the same
JP2002080447A (en) Quaternary ammonium salt compound, method for producing the same and application thereof
JPH04266912A (en) Antimicrobial agent
JPS63310803A (en) Antibacterial agent
RU2272045C1 (en) Polydiallylamines and disinfecting agent comprising thereof
JPS61179211A (en) Production of polymer of inorganic acid salt of monoallylamine or n-substituted monoallylamine
Elrod et al. Synthesis of novel N-halamine biocidal polymers
Li et al. Biocidal copolymers of N-haloacryloxymnethylhydantoin
JPH04342504A (en) Antimicrobial composition
JP3205063B2 (en) Polymerizable monomer and method for producing the same
JP3179192B2 (en) Fungicide
JP2560296B2 (en) Antifungal polymer
JP2640100B2 (en) Antifungal agent using antifungal polymer obtained from polymerizable halogen compound